Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

Arnon Nagler, Myriam Labopin, Jonathan Canaani, Riitta Niittyvuopio, Gerard Soci, Nicolaus Kroeger, Maija Itälä-Remes, Ibrahim Yakoub-Agha, Helene Labussiere-Wallet, Maria P. Gallego-Hernanz, Eric Deconinck, Patrice Chevallier, Juergen Finke, Jordi Esteve, Mohamad Mohty

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftAmerican Journal of Hematology
Volym95
Nummer10
Sidor (från-till)1135-1141
Antal sidor7
ISSN0361-8609
DOI
StatusPublicerad - okt. 2020
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här